A single hospital study on portal vein thrombosis in cirrhotic patients - Clinical characteristics & risk factors

Indian Journal of Medical Research

Volumn 139, Issue FEB, 2014, Pages 260-266

  Chen, Huisong ^a   Trilok, Goolab ^a   Wang, Fei ^a   Qi, Xiaolong ^a   Xiao, Junjie ^a   Yang, Changqing ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cirrhosis; Hepatitis B virus; Portal vein thrombosis; Risk factors; Splenic thickening

Indexed keywords

ALBUMIN; ALPHA INTERFERON; BILIRUBIN; C REACTIVE PROTEIN; FIBRINOGEN; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CHILD PUGH SCORE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PORTAL VEIN THROMBOSIS; PREVALENCE; PROTHROMBIN TIME; RISK FACTOR; THROMBOCYTE COUNT; TREATMENT OUTCOME; VERY ELDERLY; COMPLICATION; ECHOGRAPHY; HEPATITIS B VIRUS; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; PORTAL HYPERTENSION; PORTAL VEIN; RADIOGRAPHY; SPLENIC VEIN; VEIN THROMBOSIS; VIROLOGY;

AGED; FEMALE; HEPATITIS B VIRUS; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; PORTAL VEIN; RISK FACTORS; SPLENIC VEIN; VENOUS THROMBOSIS;

EID: 84897430369     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mangia A, Villani MR, Cappucci G, Santoro R, Ricciardi R, Facciorusso D, et al. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol 2005; 17: 745-751.
2. Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23796 consecutive autopsies. World J Gastroenterol 2006; 12: 2115-2119.
3. Fimognari FL, Violi F. Portal vein thrombosis in liver cirrhosis. Intern Emerg Med 2008; 3: 213-218.
4. Gaiani S, Bolondi L, Li Bassi S, Zironi G, Siringo S, Barbara L. Prevalence of spontaneous hepatofugal portal fow in liver cirrhosis. Clinical and endoscopic correlation in 228 patients. Gastroenterology 1991; 100: 160-167.
5. Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 2009; 51: 682-689.
6. Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005; 54: 691-697.
7. Webster GJ, Burroughs AK, Riordan SM. Portal vein thrombosis - new insights into aetiology and management. Aliment Pharmacol Ther 2005; 21: 1-9.
8. Harmanci O, Bayraktar Y. Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes. World J Gastroenterol 2007; 13: 2535-2540.
9. Weber A, Krebs S, Lenhardt C, Wagenpfeil S, Schmid RM, Schulte-Frohlinde E. Correlation of routinely used coagulation parameters and presence of portal vein thrombosis in patients with liver cirrhosis. Hepatol Res 2009; 39: 882-887.
10. Leebeek FW, Smalberg JH, Janssen HL. Prothrombotic disorders in abdominal vein thrombosis. Neth J Med 2012; 70: 400-405.
11. Shetty S, Ghosh K. Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis - a concise review. Thromb Res 2011; 127: 505-512.
12. Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Iannaccone L, D'Andrea G, et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 2000; 31: 345-348.
13. Denninger MH, Chait Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000; 31: 587-591.
14. Englesbe MJ, Kubus J, Muhammad W, Sonnenday CJ, Welling T, Punch JD, et al. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transplantation 2010; 16: 83-90.
15. Qi X, Bai M, Yang Z, Yuan S, Zhang C, Han G, et al. Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis. Med Hypotheses 2011; 76: 522-526.
16. Amitrano L, Anna Guardascione M, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004; 40: 736-741.
17. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fbrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-1075.
18. Kazmierczak SC, Robertson AF, Catrou PG, Briley KP, Kreamer BL, Gourley GR. Direct spectrophotometric method for measurement of bilirubin in newborns: comparison with HPLC and an automated diazo method. Clin Chem 2002; 48: 1096-1097.
19. Tripathy D, Mohanty P, Dhindsa S, Syed T, Ghanim H, Aljada A, et al. Elevation of free fatty acids induces infammation and impairs vascular reactivity in healthy subjects. Diabetes 2003; 52: 2882-2887.
20. Potapnev MP, Belevtsev MV, Bortkevich LG, Grinev VV, Martsev SP, Kravchuk ZI, et al. Signifcance of serum immunoglobulin G for leukocytosis and prognosis in childhood B-lineage acute lymphoblastic leukemia. Pediatric Blood & Cancer 2004; 42: 421-426.
21. Sabba C, Merkel C, Zoli M, Ferraioli G, Gaiani S, Sacerdoti D, et al. Interobserver and interquipment variability of echo-Doppler examination of the portal vein: effect of a cooperative training program. Hepatology 1995; 21: 428-433.
22. Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 2006; 12: 2115-2119.
23. Korn L, Chirayu A. High incidence of hepatitis B infection-associated cirrhosis and hepatocellular carcinoma in the Southeast Asian patients with portal vein thrombosis. BMC Gastroenterol 2011; 11: 66.
24. Hirohata Y, Murata A, Abe S, Otsuki M. Portal vein thrombosis associated with antiphospholipid syndrome. J Gastroenterol 2001; 36: 574-578.
25. Ushitora Y, Tashiro H, Takahashi S, Amano H, Oshita A, Kobayashi T, et al. Splenectomy in chronic hepatic disorders: portal vein thrombosis and improvement of liver function. Dig Surg 2011; 28: 9-14.
26. Zhang D, Hao J, Yang N. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis. J Gastroenterol Hepatol 2010; 25: 116-121.
27. Bajaj JS, Bhattacharjee J, Sarin SK. Coagulation profle and platelet function in patients with extrahepatic portal vein obstruction and non-cirrhotic portal fbrosis. J Gastroenterol Hepatol 2001; 16: 641-646.
28. Zoli M, Iervese T, Merkel C, Bianchi G, Magalotti D, Marchesini G, et al. Prognostic signifcance of portal hemodynamics in patients with compensated cirrhosis. J Hepatol 1993; 17: 56-61.
29. Danno K, Ikeda M, Sekimoto M, Sugimoto T, Takemasa I, Yamamoto H, et al. Diameter of splenic vein is a risk factor for portal or splenic vein thrombosis after laparoscopic splenectomy. Surgery 2009; 145: 457-464.
30. Bolognesi M, Merkel C, Sacerdoti D, Nava V, Gatta A. Role of spleen enlargement in cirrhosis with portal hypertension. Dig Liver Dis 2002; 34: 144-150.